loadpatents
name:-0.014685153961182
name:-0.011204957962036
name:-0.0058281421661377
Huang; Taisheng Patent Filings

Huang; Taisheng

Patent Applications and Registrations

Patent applications and USPTO patent grants for Huang; Taisheng.The latest application filed is for "combination therapy comprising a2a/a2b inhibitors, pd-1/pd-l1 inhibitors, and anti-cd73 antibodies".

Company Profile
9.19.31
  • Huang; Taisheng - Wilmington DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Combination Therapy Comprising A2a/a2b Inhibitors, Pd-1/pd-l1 Inhibitors, And Anti-cd73 Antibodies
App 20220233529 - Wang; Hui ;   et al.
2022-07-28
Pyrazolopyridines and triazolopyridines as A2A / A2B inhibitors
Grant 11,390,624 - Huang , et al. July 19, 2
2022-07-19
Pyrrole Tricyclic Compounds As A2a / A2b Inhibitors
App 20220213112 - Wang; Xiaozhao ;   et al.
2022-07-07
Bicyclic Dione Compounds As Inhibitors Of Kras
App 20220106309 - Huang; Taisheng ;   et al.
2022-04-07
Piperidin-4-yl azetidine derivatives as JAK1 inhibitors
Grant 11,285,140 - Huang , et al. March 29, 2
2022-03-29
Pyrrole tricyclic compounds as A2A / A2B inhibitors
Grant 11,220,510 - Wang , et al. January 11, 2
2022-01-11
Cd73 Inhibitor And A2a/a2b Adenosine Receptor Inhibitor Combination Therapy
App 20210230294 - Nastri; Horacio G. ;   et al.
2021-07-29
Combination Therapy Comprising A2A/A2B and PD-1/PD-L1 Inhibitors
App 20210205311 - Wang; Hui ;   et al.
2021-07-08
Pyrrolotriazine Compounds As Tam Inhibitors
App 20210147430 - Li; Yun-Long ;   et al.
2021-05-20
Imidazopyrimidines And Triazolopyrimidines As A2a / A2b Inhibitors
App 20210139485 - Wang; Xiaozhao ;   et al.
2021-05-13
Piperidin-4-yl Azetidine Derivatives As Jak1 Inhibitors
App 20200397774 - Huang; Taisheng ;   et al.
2020-12-24
Pyrazolopyridines And Triazolopyridines As A2a / A2b Inhibitors
App 20200270244 - Huang; Taisheng ;   et al.
2020-08-27
Piperidin-4-yl azetidine derivatives as JAK1 inhibitors
Grant 10,695,337 - Huang , et al.
2020-06-30
Pyrrolopyrimidine Derivatives As Tam Inhibitors
App 20200181151 - Li; Yun-Long ;   et al.
2020-06-11
Pyrrole Tricyclic Compounds As A2a / A2b Inhibitors
App 20190337957 - Wang; Xiaozhao ;   et al.
2019-11-07
Imidazopyrimidines And Triazolopyrimidines As A2a / A2b Inhibitors
App 20190292188 - Wang; Xiaozhao ;   et al.
2019-09-26
Pyrrolopyrimidine Derivatives As Tam Inhibitors
App 20190031663 - Li; Yun-Long ;   et al.
2019-01-31
Piperidin-4-yl Azetidine Derivatives As Jak1 Inhibitors
App 20180353499 - Huang; Taisheng ;   et al.
2018-12-13
Pyrrolotriazine Compounds As Tam Inhibitors
App 20180327412 - Li; Yun-Long ;   et al.
2018-11-15
Pyrrolopyrimidine derivatives as TAM inhibitors
Grant 10,053,465 - Li , et al. August 21, 2
2018-08-21
Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitors
Grant 10,000,507 - Li , et al. June 19, 2
2018-06-19
Piperidin-4-yl azetidine derivatives as JAK1 inhibitors
Grant 9,999,619 - Huang , et al. June 19, 2
2018-06-19
Pyrrolotriazine Compounds As Tam Inhibitors
App 20170275290 - Li; Yun-Long ;   et al.
2017-09-28
Piperidin-4-yl Azetidine Derivatives As Jak1 Inhibitors
App 20170246157 - Huang; Taisheng ;   et al.
2017-08-31
Furo- And Thieno-pyridine Carboxamide Compounds Useful As Pim Kinase Inhibitors
App 20170190716 - Li; Yun-Long ;   et al.
2017-07-06
Pyrrolopyrimidine Derivatives As Tam Inhibitors
App 20170057965 - Li; Yun-Long ;   et al.
2017-03-02
Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitors
Grant 9,556,197 - Li , et al. January 31, 2
2017-01-31
Piperidin-4-yl azetidine derivatives as JAK1 inhibitors
Grant 9,464,088 - Huang , et al. October 11, 2
2016-10-11
Piperazinylpiperidine derivatives as chemokine receptor antagonists
Grant 9,067,921 - Xue , et al. June 30, 2
2015-06-30
Furo- And Thieno-pyridine Carboxamide Compounds Useful As Pim Kinase Inhibitors
App 20150057265 - Li; Yun-Long ;   et al.
2015-02-26
Isoindolinone and pyrrolopyridinone derivatives as Akt inhibitors
Grant 8,895,571 - Huang , et al. November 25, 2
2014-11-25
Piperidin-4-yl Azetidine Derivatives As Jak1 Inhibitors
App 20140275031 - Huang; Taisheng ;   et al.
2014-09-18
Piperidin-4-yl azetidine derivatives as JAK1 inhibitors
Grant 8,765,734 - Huang , et al. July 1, 2
2014-07-01
Piperazinylpiperidine Derivatives As Chemokine Receptor Antagonists
App 20140155404 - Xue; Chu-Biao ;   et al.
2014-06-05
Piperazinylpiperidine derivatives as chemokine receptor antagonists
Grant 8,680,104 - Xue , et al. March 25, 2
2014-03-25
Isoindolinone And Pyrrolopyridinone Derivatives As Akt Inhibitors
App 20130096144 - Huang; Taisheng ;   et al.
2013-04-18
3-aminopyrrolidine derivatives as modulators of chemokine receptors
Grant 8,362,003 - Xue , et al. January 29, 2
2013-01-29
Piperazinylpiperidine Derivatives As Chemokine Receptor Antagonists
App 20120295912 - Xue; Chu-Biao ;   et al.
2012-11-22
Piperazinylpiperidine derivatives as chemokine receptor antagonists
Grant 8,268,826 - Xue , et al. September 18, 2
2012-09-18
3-aminopyrrolidine Derivatives As Modulators Of Chemokine Receptors
App 20110251168 - Xue; Chu-Biao ;   et al.
2011-10-13
Piperidin-4-yl Azetidine Derivatives As Jak1 Inhibitors
App 20110224190 - Huang; Taisheng ;   et al.
2011-09-15
Piperazinylpiperidine derivatives as chemokine receptor antagonists
Grant 7,678,798 - Xue , et al. March 16, 2
2010-03-16
3-Aminopyrrolidine Derivatives As Modulators Of Chemokine Receptors
App 20090247474 - Xue; Chu-Biao ;   et al.
2009-10-01
Piperazinylpiperidine Derivatives As Chemokine Receptor Antagonists
App 20090197887 - XUE; Chu-Biao ;   et al.
2009-08-06
3-Aminopyrrolidine derivaties as modulators of chemokine receptors
App 20060252751 - Xue; Chu-Biao ;   et al.
2006-11-09
Piperazinylpiperidine derivatives as chemokine receptor antagonists
App 20050261310 - Xue, Chu-Biao ;   et al.
2005-11-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed